Case Based Panel Discussion - EGFR - Exon 20 Mutation, Treatment, Targeted Therapy, Clinical Trials

dbrock's picture

Submitted by dbrock on Wed, 03/25/2020 - 12:07

H. Jack West, MD, Founder, President and CEO
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Heather Wakelee and Caroline McCoach.

Dr. Wakelee is Professor of Medicine in the Division of Medicine and Oncology at Stanford University Medical Center. Dr. McCoach is Assistant Professor in the Thoracic Medical Oncology Division of the UCSF Helen Diller Comprehensive Cancer Center in San Francisco, California.

In this series, the doctors discuss a series of cases related to an EGFR mutation. In this video, the discussion is regarding the EGFR uncommon EXON 20 mutation, suggested treatments, targeted therapy and clinical trials.

 

 

To join the conversation, visit https://cancergrace.org/forum.  

For a full listing of these case based discussions, please visit https://cancergrace.org/sponsor/case-based-panel-discussions-2019-lung-cancer.

Related Content: 
adenocarcinoma stage 4 exon 20 mutation - 1263489
Targeted therapy for Exon20
EGFR – Exon 19 deletion - 1263520
EXON 20 and ERBB3 amplification - is Afatinib really an option? - 1264755
Tarceva after Surgery?? - NSCLC EGFR Exon deletion 19 Stage IIIB - 1265351
EGFR + but exon 18 G719X - 1269316
Exon 20 mutation - 1272525
is Tagrisso equally effective on T790M and the original EGFR exon 19 mutation? - 1273499
T790M mutation gone , but original EGFR exon 19 unchanged with Tagrisso - 1288931
Exon 18 - 1291031
Video Language: 
English

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation